These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24815864)

  • 1. Overexpression of the EMT driver brachyury in breast carcinomas: association with poor prognosis.
    Palena C; Roselli M; Litzinger MT; Ferroni P; Costarelli L; Spila A; Cavaliere F; Huang B; Fernando RI; Hamilton DH; Jochems C; Tsang KY; Cheng Q; Lyerly HK; Schlom J; Guadagni F
    J Natl Cancer Inst; 2014 May; 106(5):. PubMed ID: 24815864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of epithelial-mesenchymal transition driver brachyury and status of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in predicting treatment responses to neoadjuvant chemotherapy of breast cancer.
    Lee KH; Kim EY; Park YL; Do SI; Chae SW; Park CH
    Tumour Biol; 2017 Jun; 39(6):1010428317710575. PubMed ID: 28621227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer.
    Roselli M; Fernando RI; Guadagni F; Spila A; Alessandroni J; Palmirotta R; Costarelli L; Litzinger M; Hamilton D; Huang B; Tucker J; Tsang KY; Schlom J; Palena C
    Clin Cancer Res; 2012 Jul; 18(14):3868-79. PubMed ID: 22611028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-box transcription factor Brachyury expression is correlated with epithelial-mesenchymal transition and lymph node metastasis in oral squamous cell carcinoma.
    Imajyo I; Sugiura T; Kobayashi Y; Shimoda M; Ishii K; Akimoto N; Yoshihama N; Kobayashi I; Mori Y
    Int J Oncol; 2012 Dec; 41(6):1985-95. PubMed ID: 23076115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of the embryonic transcription factor brachyury in human tumors detected with a novel rabbit monoclonal antibody.
    Hamilton DH; Fernando RI; Schlom J; Palena C
    Oncotarget; 2015 Mar; 6(7):4853-62. PubMed ID: 25605015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.
    Du R; Wu S; Lv X; Fang H; Wu S; Kang J
    J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells.
    Shimoda M; Sugiura T; Imajyo I; Ishii K; Chigita S; Seki K; Kobayashi Y; Shirasuna K
    BMC Cancer; 2012 Aug; 12():377. PubMed ID: 22931165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer vaccines targeting the epithelial-mesenchymal transition: tissue distribution of brachyury and other drivers of the mesenchymal-like phenotype of carcinomas.
    Hamilton DH; Litzinger MT; Fernando RI; Huang B; Palena C
    Semin Oncol; 2012 Jun; 39(3):358-66. PubMed ID: 22595058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of Brachyury in inducing epithelial-to-mesenchymal transition (EMT) and HIF-1α expression in breast cancer cells.
    Shao C; Zhang J; Fu J; Ling F
    Biochem Biophys Res Commun; 2015 Nov; 467(4):1083-9. PubMed ID: 26393908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells.
    Fernando RI; Castillo MD; Litzinger M; Hamilton DH; Palena C
    Cancer Res; 2011 Aug; 71(15):5296-306. PubMed ID: 21653678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brachyury, a vaccine target, is overexpressed in triple-negative breast cancer.
    Hamilton DH; Roselli M; Ferroni P; Costarelli L; Cavaliere F; Taffuri M; Palena C; Guadagni F
    Endocr Relat Cancer; 2016 Oct; 23(10):783-796. PubMed ID: 27580659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Brachyury gene is a significant prognostic factor for primary lung carcinoma.
    Haro A; Yano T; Kohno M; Yoshida T; Koga T; Okamoto T; Takenoyama M; Maehara Y
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S509-16. PubMed ID: 23456319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brachyury oncogene is a prognostic factor in high-risk testicular germ cell tumors.
    Pinto F; Cárcano FM; da Silva ECA; Vidal DO; Scapulatempo-Neto C; Lopes LF; Reis RM
    Andrology; 2018 Jul; 6(4):597-604. PubMed ID: 29749711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding Molecular Pathways and Targets of Brachyury in Epithelial-mesenchymal Transition (EMT) in Human Cancers.
    Song W; Gobe GC
    Curr Cancer Drug Targets; 2016; 16(7):586-93. PubMed ID: 27018266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The T-box transcription factor Brachyury promotes epithelial-mesenchymal transition in human tumor cells.
    Fernando RI; Litzinger M; Trono P; Hamilton DH; Schlom J; Palena C
    J Clin Invest; 2010 Feb; 120(2):533-44. PubMed ID: 20071775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivation of SOX5 by Brachyury promotes breast cancer bone metastasis.
    Chen M; Zou S; He C; Zhou J; Li S; Shen M; Cheng R; Wang D; Zou T; Yan X; Huang Y; Shen J
    Carcinogenesis; 2020 Jul; 41(5):551-560. PubMed ID: 31713604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological targeting of tumor cells undergoing an epithelial-mesenchymal transition via a recombinant brachyury-yeast vaccine.
    Hamilton DH; Litzinger MT; Jales A; Huang B; Fernando RI; Hodge JW; Ardiani A; Apelian D; Schlom J; Palena C
    Oncotarget; 2013 Oct; 4(10):1777-90. PubMed ID: 24125763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brachyury promotes tamoxifen resistance in breast cancer by targeting SIRT1.
    Li K; Ying M; Feng D; Du J; Chen S; Dan B; Wang C; Wang Y
    Biomed Pharmacother; 2016 Dec; 84():28-33. PubMed ID: 27621036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis.
    Tucker JA; Jochems C; Boyerinas B; Fallon J; Greiner JW; Palena C; Rodell TC; Schlom J; Tsang KY
    Cancer Immunol Immunother; 2014 Dec; 63(12):1307-17. PubMed ID: 25186612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning based tissue analysis reveals Brachyury has a diagnosis value in breast cancer.
    Li K; Wang Q; Lu Y; Pan X; Liu L; Cheng S; Wu B; Song Z; Gao W
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33734319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.